Laserfiche WebLink
65 <br /> <br />V. CONCEPT OF OPERATIONS: <br />Key response actions by phase as identified by the World Health Organization (WHO), <br />specifically “phase 4” when “community-level outbreaks has been verified.” <br />A. PHASE 4 <br /> 1. Disseminate surveillance guidelines to physicians, clinics, and hospitals <br /> 2. Track possible cases identified in Kittitas County <br /> 3. Establish case definition that aligns with Department of Health and Human <br /> Services (HHS), CDC, and DOH. <br /> 4. The Public Information Officer (PIO) or designee will develop information <br /> related to pandemic influenza activity and forward to media and news sources. <br /> 5. KCPHD will develop and disseminate guidelines regarding antivirals based on <br /> guidance from CDC and DOH. <br /> 6. Develop public information messaging based on expected amounts of vaccine and <br /> priority groups. <br /> <br />B. PHASE 5 <br /> <br /> 1. Develop or refine protocol for active surveillance at KVH and other facilities. <br /> 2. Provide healthcare sites with instructions about gathering samples from individuals <br /> who display symptoms of influenza like illness (ILI) and who are at increased risk for <br /> infection according to established guidelines. <br /> 3. PIO or designee will disseminate information regarding status of outbreak to all <br /> healthcare providers and other facilities at regular intervals. <br /> 4. Implement plans for requesting any available drugs through state, federal, or private <br /> sources. <br /> 5. Monitor adverse reactions to antiviral medications under the guidance of CDC and <br /> DOH. <br /> 6. Distribute antivirals to priority groups. <br /> <br />C. PHASE 6 <br /> <br /> 1. Screen and/or quarantine international travelers recently arriving in Kittitas County <br /> from an area known and/or suspected to be infected, following federal guidelines. <br /> 2. Continue to monitor workforce absenteeism within the community through reporting <br /> from major employers. <br /> 3. Review surveillance data for potential risk factors that either prioritize or deprioritize <br /> infected individuals for receiving antivirals and/or vaccine, following state and federal <br /> guidelines. <br /> 4. Set up a call-in line for healthcare professionals to answer questions relating to the <br /> pandemic (unpublished call in line – not for general public). <br /> 5. Distribute antivirals to priority groups. <br /> 6. Monitor adverse reactions as resources permit. <br /> 7. Monitor any cases of resistance to antivirals.